Evidence map›Paper›PMID 40863531›Full record

ArticleJournal of fungi (Basel, Switzerland)2025

Biodegradation of Chloroquine by a Fungus from Amazonian Soil,

Patrícia de Almeida Nóbrega, Samuel Q Lopes, Lucas S Sá, Ryan da Silva Ramos, Fabrício H E Holanda, Inana F de Araújo, André Luiz M Porto, Willian G Birolli, Irlon M Ferreira

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Patrícia de Almeida NóbregaBiocatalysis and Applied Organic Synthesis Laboratory, Federal University of Amapá, Macapá 68903-419, AP, Brazil.ORCID 0000-0002-6010-1300
Samuel Q LopesBiocatalysis and Applied Organic Synthesis Laboratory, Federal University of Amapá, Macapá 68903-419, AP, Brazil.
Lucas S SáBiocatalysis and Applied Organic Synthesis Laboratory, Federal University of Amapá, Macapá 68903-419, AP, Brazil.
Ryan da Silva RamosPost-Graduate Program in Biotechnology and Biodiversity-BIONORTE Network, Federal University of Amapá, Macapá 68902-280, AP, Brazil.
Fabrício H E HolandaFederal Institute of Science and Technology Education of Amapá, Rua Nilo Perçanha, Bairro Cajari, Laranjal do Jari 68920-000, AP, Brazil.
Inana F de AraújoBiocatalysis and Applied Organic Synthesis Laboratory, Federal University of Amapá, Macapá 68903-419, AP, Brazil.
André Luiz M PortoLaboratory of Organic Chemistry and Biocatalysis, São Carlos Institute of Chemistry, University of São Paulo, Ed. Prof. Douglas Wagner Franco, Av. João Dagnone 1100, Santa Angelina, São Carlos 13563-120, SP, Brazil.
Willian G BirolliMolecular Oncology Research Center, Educational and Research Institute, Barretos Cancer Hospital, Av. Ébano 165-1, Dr. Paulo Prata, Barretos 14784-384, SP, Brazil.ORCID 0000-0001-7859-1830
Irlon M FerreiraBiocatalysis and Applied Organic Synthesis Laboratory, Federal University of Amapá, Macapá 68903-419, AP, Brazil.ORCID 0000-0002-4517-0105

Funding

National Council for Scientific and Technological Development 141512/2024-5
6 · The paper itself

Abstract

Concern over the presence of pharmaceutical waste in the environment has prompted research into the management of emerging organic micropollutants (EOMs). In response, sustainable technologies have been applied as alternatives to reduce the effects of these contaminants. This study investigated the capacity of filamentous fungi isolated from iron mine soil in the Amazon region to biodegrade the drug chloroquine diphosphate. An initial screening assessed the growth of four fungal strains on solid media containing chloroquine diphosphate:

Indexed as

Amazonian fungibiodegradationCOVID-19environmental pollutionpharmaceutical compounds

Identifiers

PMID40863531
PMCPMC12387243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.